Wanted: Biotech Startups in New York City
Officials Visit Microsoft's China Offices -- Update
Roche Profit Dented by Currencies
Drug Companies Oppose Moves to Reimburse Off-Label Medicine
Roche to buy Seragon for up to $1.725 billion
EUROPE MARKETS: Alcatel, Roche Up In Europe, But Orange Shares Sour
UPDATE: Alcatel, Roche up in Europe, but Orange shares sour
While a majority of our top fund managers are outperforming this year, three of them truly stand out from the rest given their ability to outperform the market over all time periods.
This fund's comeback from the financial crisis has been balky, but it still has promise.